NursingPlex
    Sign In
    Pharmacology proctored examQuestion 39
    39 / 50
    Pharmacology proctored exam

    The black box warnings concerning teens and young adults taking antidepressants include:

    Explanation & Rationale

    Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are commonly used in adolescents and young adults to treat major depressive disorder and anxiety disorders. While effective in improving mood and function, these medications carry important safety concerns during the early phase of treatment. One of the most significant risks identified in this population is a potential increase in suicidal thoughts and behaviors. This risk is most prominent during initiation or dose changes, requiring close monitoring. Rationale: A. Suicidal ideation is the key black box warning associated with antidepressant use in adolescents and young adults, including agents like Selective serotonin reuptake inhibitors (SSRIs). The warning highlights the increased risk of worsening depression or emergence of suicidal thoughts during early treatment. This necessitates careful monitoring, frequent follow-up, and patient and family education about behavioral changes. B. Growth retardation is not a recognized black box warning for antidepressant medications. While some psychotropic drugs may have indirect effects on appetite or weight, there is no established boxed warning regarding impaired growth in teens taking antidepressants. This option reflects a misunderstanding of antidepressant safety concerns. C. Agranulocytosis is a severe hematologic adverse effect associated with certain medications such as clozapine, not antidepressants. SSRIs and most antidepressants do not carry a black box warning for bone marrow suppression or severe neutropenia. Therefore, this is not relevant to antidepressant safety in youth. D. Increased use of recreational drugs is not a documented black box warning for antidepressant therapy. While substance use may co-occur with depression in adolescents, antidepressants themselves are not associated with causing increased recreational drug use. This is not part of FDA-mandated safety warnings for this medication class.

    🔒 Submit your answer to reveal